RRMM-Relapsed or Refractory Multiple Myeloma
Showing 9976 - 10000 of >10,000
Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 16, 2023
Multiple Sclerosis Trial in Athens (Lifestyle intervention)
Completed
- Multiple Sclerosis
- Lifestyle intervention
-
Athens, GreeceIaso Hospital
Dec 14, 2021
Acute Ischemic Stroke Trial in Cypress (LT3001 drug product, Placebo, Aspirin)
Recruiting
- Acute Ischemic Stroke
- LT3001 drug product
- +5 more
-
Cypress, CaliforniaLumosa Phase 1 Unit
Mar 17, 2021
Severe Asthma Trial in Belgium (Randomisation to omalizumab, Randomisation to mepolizumab)
Recruiting
- Severe Asthma
- Randomisation to omalizumab
- Randomisation to mepolizumab
-
Brussel, Brussels, Belgium
- +12 more
Nov 2, 2020
Healthy Trial in Mannheim (BI 764198, Matching )
Completed
- Healthy
- BI 764198
- Matching placebo
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Nov 2, 2020
Small Cell Lung Cancer Trial in Seoul (Olaparib)
Completed
- Small Cell Lung Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 16, 2021
Relapsing-Remitting Multiple Sclerosis Trial in Berlin (Prolonged Fasting, Ketogenic low glycemic load treatment, Control diet)
Completed
- Relapsing-Remitting Multiple Sclerosis
- Prolonged Fasting
- +2 more
-
Berlin, GermanyCharité-Universitätsmedizin
Apr 6, 2021
Rheumatoid Arthritis (RA), Inflammatory Bowel Disease - IBD1 Trial in Guizhou (ZL-82 12.5mg, ZL-82 25mg, ZL-82 50mg)
Recruiting
- Rheumatoid Arthritis (RA)
- Inflammatory Bowel Disease - IBD1
- ZL-82 12.5mg
- +7 more
-
Guizhou, GuiYang, ChinaAffiliated Hospital of Guizhou Medical University
Sep 19, 2023
Functional Disorder Trial (Acceptance and Commitment Therapy)
Completed
- Functional Disorder
- Acceptance and Commitment Therapy
- (no location specified)
Jun 9, 2021
MDD Trial in Toronto (MR-guided Focused Ultrasound)
Recruiting
- Major Depressive Disorder
- MR-guided Focused Ultrasound
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Mar 15, 2021
Parkinson Disease Trial in Worldwide (ExAblate Pallidotomy, Sham ExAblate Pallidotomy)
Active, not recruiting
- Parkinson Disease
- ExAblate Pallidotomy
- Sham ExAblate Pallidotomy
-
Stanford, California
- +19 more
Nov 5, 2020
Quality of Life AfterMultidisciplinary Auditory Rehabilitation
Active, not recruiting
- Acquired Deafness
-
Paris, FranceHôpital Sainte-Marie
Oct 31, 2022
Idiopathic Pulmonary Fibrosis Trial in London (Morphine Sulfate, Placebo oral tablet)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Morphine Sulfate
- Placebo oral tablet
-
London, United KingdomRoyal Brompton Hospital
May 25, 2022
Endometrial Polyp Benign, Retained Products of Conception, Myoma;Uterus Trial in Genk, Leuven (Hysteroscopic morcellation 19 Fr.
Recruiting
- Endometrial Polyp Benign
- +2 more
- Hysteroscopic morcellation 19 Fr. intrauterine BIGATTI Shaver for uterine intracavitary lesions
-
Genk, Belgium
- +1 more
Mar 30, 2023
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Best Practice, Ibrutinib, Patient Derived
Unknown status
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Best Practice
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2020
Trauma Specific Frailty Index
Recruiting
- Physical Trauma
- Trauma Specific Frailty Index Questionnaire
-
Dallas, TexasMethodist Dallas Medical Center
Dec 9, 2021
Well-Being, Psychological Trial (Genetic)
Not yet recruiting
- Well-Being, Psychological
- Genetic
- (no location specified)
Sep 14, 2023
Burns, Infection Wound, Bacterial Infections Trial in Lubbock (Open-to-air strategy, Traditional closed-wound management)
Withdrawn
- Burns
- +2 more
- Open-to-air strategy
- Traditional closed-wound management
-
Lubbock, TexasTexas Tech University Health Sciences Center
Dec 14, 2021
Obsessive Compulsive Disorder (OCD) Trial in New York (Selective focal stimulation of ALIC-pathways)
Recruiting
- Obsessive Compulsive Disorder (OCD)
- Selective focal stimulation of ALIC-pathways
-
New York, New YorkMount Sinai West
Jan 4, 2022
Multiple Sclerosis and Voiding Symptoms: How to Assess?
Completed
- Multiple Sclerosis
- +2 more
- voiding phase evaluation
-
Paris, FranceDepartment of Neuro- Urology, Hôpital Tenon
Jun 18, 2021
Multiple Myeloma, Minimal Residual Disease, High-Risk Cancer Trial in New York (WT1 Analog Peptide Vaccine, Sargramostim
Unknown status
- Multiple Myeloma
- +2 more
- WT1 Analog Peptide Vaccine
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 6, 2020
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis Trial in United States
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- +6 more
- Naltrexone Hydrochloride
- Placebo Comparator
-
Boston, Massachusetts
- +6 more
Jan 25, 2022
Tumors, CNS, Pediatric Brain Tumor, Malignant Brain Tumor Trial in China (Tumour resection)
Completed
- Tumors, Central Nervous System
- +3 more
- Tumour resection
-
Hefei, Anhui, China
- +37 more
Aug 31, 2021